---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-104896"
form_type: "8-K"
ticker: "OSRH"
cik: "0001840425"
company_name: "OSR Holdings, Inc."
filed_at: "2024-04-22T23:59:59+00:00"
generated_at: "2026-06-03T14:21:54.479287+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Bellevue Life Sciences gets Nasdaq extension to Aug 13, 2024 for 300 public holders; issues $50K note to sponsor

## Summary
- Received Nasdaq extension to demonstrate minimum 300 public holders by August 13, 2024; previously failed compliance.
- Issued $50,000 unsecured promissory note to sponsor Bellevue Global Life Sciences Investors LLC, non-interest bearing.
- Note due December 31, 2024 or upon initial business combination; principal forgiven if no deal consummated.
- Failure to meet Nasdaq public-holder requirement by deadline could result in delisting of securities.

## SEC filing metadata
- accession: 0001193125-24-104896
- form_type: 8-K
- ticker: OSRH
- cik: 0001840425
- company_name: OSR Holdings, Inc.
- filed_at: 2024-04-22T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840425/000119312524104896/0001193125-24-104896-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840425/000119312524104896/d828353d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-104896
- JSON: https://secwatch.observer/filing/0001193125-24-104896.json
- Plain text: https://secwatch.observer/filing/0001193125-24-104896.txt

## Key facts
- Debt Financings
  OSR Holdings, Inc. incurred loan of $50,000 with Bellevue Global Life Sciences Investors LLC at not interest bearing maturing December 31, 2024 or the date on which the Company consummates an initial business combination.
  - Instrument: loan
  - Principal: $50,000
  - Counterparty: Bellevue Global Life Sciences Investors LLC
  - Rate: not interest bearing
  - Maturity: December 31, 2024 or the date on which the Company consummates an initial business combination
  - Event: incurrence
  source text: On April 17, 2024, Bellevue Life Sciences Acquisition Corp. (the “ Company ”) issued an unsecured promissory note (the “ Promissory Note ”) in the principal amount of $50,000 to Bellevue Global Life Sciences Investors LLC (“ BGLSI ”), the sponsor of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840425/000119312524104896/0001193125-24-104896-index.htm
- Listing & Compliance Notices
  OSR Holdings, Inc. received a nasdaq extension granted notice regarding shareholders (rules 5550(a)(3)).
  - Exchange: nasdaq
  - Notice: extension granted
  - Deficiency: shareholders
  - Rules: 5550(a)(3)
  source text: April 17, 2024, the Company received a written notice from Nasdaq indicating that the staff of Nasdaq (the “ Staff ”) has determined, based on its review of the Company’s compliance plan, to grant the Company an extension of time to regain compliance with the Minimum Public Holders Requirement. The terms of the extension are as follows: on or before August 13, 2024, the Company must file with Nasdaq documentation from its transfer agent, or independent source, that demonstrates that its common stock has a minimum of 300 public holders. In the event the Company does not satisfy the terms, the S
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840425/000119312524104896/0001193125-24-104896-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.